Intravitreal Dexamethasone Implant for the Treatment of Postoperative Macular Edema

Ophthalmologica

Volumn 236, Issue 4, 2017, Pages 181-185

  Klamann, André ^a   Böttcher, Katharina ^a   Ackermann, Philipp ^a   Geerling, Gerd ^a   Schargus, Marc ^a   Guthoff, Rainer ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Dexamethasone implant; intravitreal injection; Irvine Gass syndrome; Postoperative macular edema

Indexed keywords

DEXAMETHASONE; DRUG IMPLANT; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CATARACT EXTRACTION; CENTRAL MACULAR THICKNESS; CLINICAL ARTICLE; DRUG EFFICACY; DRUG IMPLANT; DRUG IMPLANTATION; ENDOPHTHALMITIS; FEMALE; GLIOSIS; HUMAN; INTRAOCULAR PRESSURE; MACULAR EDEMA; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE MACULAR EDEMA; REIMPLANTATION; RETINA DETACHMENT; RETINA MACULA HOLE; VERY ELDERLY; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE; ADVERSE EFFECTS; FOLLOW UP; INTRAVITREAL DRUG ADMINISTRATION; OPTICAL COHERENCE TOMOGRAPHY; PHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CATARACT EXTRACTION; DEXAMETHASONE; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VITRECTOMY;

EID: 85001817332     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000448057     Document Type: Article

References (25)

1. Mohammadpour M, Jafarinasab MR, Javadi MA: Outcomes of acute postoperative inflammation after cataract surgery. Eur J Ophthalmol 2007; 17: 20-28.
2. Jampol LM, Sanders DR, Kraff MC: Prophylaxis and therapy of aphakic cystoid macular edema. Surv Ophthalmol 1984; 28(suppl): 535-539.
3. Stark WJ Jr, Maumenee AE, Fagadau W, Datiles M, Baker CC, Worthen D, Klein P, Auer C: Cystoid macular edema in pseudophakia. Surv Ophthalmol 1984; 28(suppl):442-451.
4. Miyake K, Ibaraki N: Prostaglandins and cystoid macular edema. Surv Ophthalmol 2002; 47(suppl 1):S203-S218.
5. Xu H, Chen M, Forrester JV, Lois N: Cataract surgery induces retinal pro-inflammatory gene expression and protein secretion. Invest Ophthalmol Vis Sci 2011; 52: 249-255.
6. Nelson ML, Martidis A: Managing cystoid macular edema after cataract surgery. Curr Opin Ophthalmol 2003; 14: 39-43.
7. Tranos PG, Wickremasinghe SS, Stangos NT, Topouzis F, Tsinopoulos I, Pavesio CE: Macular edema. Surv Ophthalmol 2004; 49: 470-490.
8. Arevalo JF, Maia M, Garcia-Amaris RA, Roca JA, Sanchez JG, Berrocal MH, Wu L; Pan-American Collaborative Retina Study Group: Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results. Ophthalmology 2009; 116: 1481-1487, 1487.e1.
9. Ghasemi Falavarjani K, Parvaresh MM, Modarres M, Hashemi M, Samiy N: Intravitreal bevacizumab for pseudophakic cystoid macular edema; a systematic review. J Ophthalmic Vis Res 2012; 7: 235-239.
10. Zarranz-Ventura J, Carreno E, Johnston RL, Mohammed Q, Ross AH, Barker C, Fonollosa A, Artaraz J, Pelegrin L, Adan A, Lee RW, Dick AD, Sallam A: Multicenter Study of Intravitreal Dexamethasone Implant in Noninfectious Uveitis: Indications, Outcomes, and Reinjection Frequency. Am J Ophthalmol 2014; 158: 1136-1145.e5.
11. Hunter RS, Lobo AM: Dexamethasone intravitreal implant for the treatment of noninfectious uveitis. Clin Ophthalmol 2011; 5: 1613-1621.
12. Myung JS, Aaker GD, Kiss S: Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant. Clin Ophthalmol 2010; 4: 1423-1426.
13. Lowder C, Belfort R Jr, Lightman S, Foster CS, Robinson MR, Schiffman RM, Li XY, Cui H, Whitcup SM, Ozurdex HSG: Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol 2011; 129: 545-553.
14. Boyer DS, Yoon YH, Belfort R Jr, Bandello F, Maturi RK, Augustin AJ, Li XY, Cui H, Hashad Y, Whitcup SM, Ozurdex MSG: Threeyear, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 2014; 121: 1904-1914.
15. Parravano M, Oddone F, Boccassini B, Giorno P, Chiaravalloti A, Tedeschi M, Scarinci F, Varano M: Exploring the morphological and functional retinal changes after dexamethasone intravitreal implant (Ozurdex ®) in macular edema due to retinal vein occlusion. Ophthalmic Res 2014; 51: 153-160.
16. Irvine SR: A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol 1953; 36: 599-619.
17. Gass JD, Norton EW: Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study. Arch Ophthalmol 1966; 76: 646-661.
18. Benitah NR, Arroyo JG: Pseudophakic cystoid macular edema. Int Ophthalmol Clin 2010; 50: 139-153.
19. Catier A, Tadayoni R, Massin P, Gaudric A: Advantages of acetazolamide associated with anti-inflammatory medications in postoperative treatment of macular edema (in French). J Fr Ophtalmol 2005; 28: 1027-1031.
20. Cox SN, Hay E, Bird AC: Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol 1988; 106: 1190-1195.
21. Schmitz K, Maier M, Clemens CR, Hohn F, Wachtlin J, Lehmann F, Bertelmann T, Rudiger K, Horn M, Bezatis A, Spital G, Meyer CH; German Retinal Vein Occlusion Group: Reliability and safety of intravitreal Ozurdex injections. The ZERO study (in German). Ophthalmologe 2014; 111: 44-52.
22. Koutsandrea C, Moschos MM, Brouzas D, Loukianou E, Apostolopoulos M, Moschos M: Intraocular triamcinolone acetonide for pseudophakic cystoid macular edema: optical coherence tomography and multifocal electroretinography study. Retina 2007; 27: 159-164.
23. Dutra Medeiros M, Navarro R, Garcia-Arumi J, Mateo C, Corcostegui B: Dexamethasone intravitreal implant for treatment of patients with recalcitrant macular edema resulting from Irvine-Gass syndrome. Invest Ophthalmol Vis Sci 2013; 54: 3320-3324.
24. Bellocq D, Korobelnik JF, Burillon C, Voirin N, Dot C, Souied E, Conrath J, Milazzo S, Massin P, Baillif S, Kodjikian L: Effectiveness and safety of dexamethasone implants for post-surgical macular oedema including Irvine-Gass syndrome: the EPISODIC study. Br J Ophthalmol 2015; 99: 979-983.
25. London NJ, Chiang A, Haller JA: The dexamethasone drug delivery system: indications and evidence. Adv Ther 2011; 28: 351-366.